Drug Type Radiopharmaceuticals and diagnostic agent, Radionuclide Drug Conjugates (RDC) |
Synonyms- |
Target |
Mechanism FAP modulators(Fibroblast activation protein alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastrointestinal cancer metastatic | Phase 1 | IR | 23 Sep 2022 | |
Gastrointestinal cancer metastatic | Phase 1 | IR | 23 Sep 2022 | |
Metastatic breast cancer | Phase 1 | IR | 23 Sep 2022 | |
Metastatic breast cancer | Phase 1 | IR | 23 Sep 2022 |